AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 98.40K | -- | -- | -- | -- |
| Total Revenue | 98.40K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 98.40K | -- | -- | -- | -- |
| SG&A Expenses | 1.40M | 1.43M | 1.48M | 1.41M | 1.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.75M | 1.80M | 1.76M | 1.61M | 1.54M |
| Operating Income | -1.65M | -1.80M | -1.76M | -1.61M | -1.54M |
| Income Before Tax | -1.65M | -1.80M | -1.76M | -1.61M | -1.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.65 | -1.80 | -1.76 | -1.61 | -1.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.65M | -1.80M | -1.76M | -1.61M | -1.54M |
| EBIT | -1.65M | -1.80M | -1.76M | -1.61M | -1.54M |
| EBITDA | -1.65M | -1.80M | -1.76M | -1.61M | -1.54M |
| EPS Basic | -0.10 | -0.11 | -0.12 | -0.12 | -0.12 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.07 | -0.07 | -0.08 |
| EPS Diluted | -0.10 | -0.11 | -0.12 | -0.12 | -0.12 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.07 | -0.07 | -0.08 |
| Average Basic Shares Outstanding | 64.30M | 64.30M | 60.95M | 56.57M | 51.84M |
| Average Diluted Shares Outstanding | 64.30M | 64.30M | 60.95M | 56.57M | 51.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |